MivazerolAlternative Names: UCB 22073
Latest Information Update: 26 Nov 1999
At a glance
- Originator UCB
- Class Anti-ischaemics
- Mechanism of Action Alpha 2 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Perioperative ischaemia; Tachycardia